These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds. Kolber MR; Korownyk C Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142 [TBL] [Abstract][Full Text] [Related]
4. Aspirin in primary and secondary prevention in elderly adults revisited. Wilson R; Gazzala J; House J South Med J; 2012 Feb; 105(2):82-6. PubMed ID: 22267096 [TBL] [Abstract][Full Text] [Related]
5. Aspirin resistance in the era of personalized medicine: Should we not take it personally? Naimo PS; McGiffin D; Konstantinov IE J Thorac Cardiovasc Surg; 2015 Dec; 150(6):e99-100. PubMed ID: 26463652 [No Abstract] [Full Text] [Related]
6. Who can resist aspirin? Smith PS Nursing; 2005 Feb; 35(2):20. PubMed ID: 15706257 [No Abstract] [Full Text] [Related]
7. Laboratory detection of 'aspirin resistance': what test should we use (if any)? Cattaneo M Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540 [No Abstract] [Full Text] [Related]
15. Studies show aspirin affects women differently than men. Heart Advis; 2006 Oct; 9(10):7. PubMed ID: 17219643 [No Abstract] [Full Text] [Related]
16. Secondary prevention of cardiovascular disease with vorapaxar: a new era of 3-drug antiplatelet therapy? Krantz MJ; Kaul S JAMA Intern Med; 2015 Jan; 175(1):9-10. PubMed ID: 25365757 [No Abstract] [Full Text] [Related]
17. Drug delivery and therapeutic impact of extended-release acetylsalicylic acid. Bliden KP; Patrick J; Pennell AT; Tantry US; Gurbel PA Future Cardiol; 2016 Jan; 12(1):45-58. PubMed ID: 26356085 [TBL] [Abstract][Full Text] [Related]
18. [Aspirin resistance candidate genes and their association with the risk of fatal cardiovascular events]. Grinshtein YI; Kosinova AA; Grinshtein IY Ter Arkh; 2013; 85(5):95-100. PubMed ID: 23819347 [TBL] [Abstract][Full Text] [Related]
19. A brief review on high on-aspirin residual platelet reactivity. Pettersen AA; Arnesen H; Seljeflot I Vascul Pharmacol; 2015; 67-69():6-9. PubMed ID: 25869498 [TBL] [Abstract][Full Text] [Related]